MLPA® Kits

For a description how to create and adapt MLPA Kits, that are not available on this page, please have a look at our User Manual MLPA.

Import of SALSA MLPA® kit descriptions via the SEQUENCE Pilot operation "Mixes [master file] / button [Import]".

Mix
Version
Date
Region
Application
Vs. 04
17-10-2006
ERBB2 (HER2-NEU) 17q21.1 Cancer
Vs. 12
07-11-2007
various Tumor suppressor genes
Vs. 11
07-05-2012
various Tumor suppressor genes
Vs. 04
08-05-2007
various Tumor suppressor genes
Vs. 14
10-07-2012
various Tumor suppressor genes
Vs. 18
01-03-2013
various Tumor suppressor genes
Vs. 02
15-10-2010
various Tumor suppressor genes
ME011-B1 Vs. 17 28-05-2012 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
ME011-B1 Vs. 19 20-12-2012 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
ME011-B2 Vs. 20 19-11-2013 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
ME011-B2 Vs. 22 30-10-2014 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
ME011-B3 Vs. 24 26-10-2016 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
ME011-B3 Vs. 25 06-12-2016 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
ME011-B3 Vs. 26 15-02-2017 MLH1, MSH2, MSH6, MLH3, MSH3 Mismatch repair genes (MMR)
Vs. 15
10-07-2009
9p21, CDKN2A, CDKNA2B

Tumours, Cutaneous melanoma

Vs. 20
07-01-2013 9p21, CDKN2A, CDKNA2B

Tumours, Cutaneous melanoma

Vs. 21
29-07-2015 9p21, CDKN2A, CDKNA2B

Tumours, Cutaneous melanoma

Vs. 44
24-02-2012
PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 45 10-10-2012 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 47 04-01-2013 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 48 01-03-2013 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 49 12-07-2013 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 50 30-01-2014 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 51 22-04-2014 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 52 22-07-2015 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-B2 Vs. 53 14-01-2016 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-C1 Vs. 55 23-12-2016 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-C1 Vs. 56 23-03-2017 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
ME028-C1 Vs. 58 10-08-2017 PWS/AS region (15q11-13), MKRN3, MAGEL2, NDN, SNRPN, UBE3A, ATP10A, GABRB3, OCA2 Prader Willi syndrome (PWS),
Angelman syndrome (AS)
Vs. 09
02-12-2010
FMR1, AFF2 Fragile X
Vs. 11
13-01-2012
FMR1, AFF2 Fragile X
ME029-B2
Vs. 13
20-12-2012
FMR1, AFF2 Fragile X
ME029-B3
Vs. 16
08-07-2016
FMR1, AFF2 Fragile X
ME029-B3
Vs. 18
18-05-2017
FMR1, AFF2 Fragile X
ME030-C3 Vs. 27 22-10-2012 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
ME030-C3 Vs. 28 20-12-2012 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
ME030-C3 Vs. 29 18-02-2013 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
ME030-C3 Vs. 30 15-10-2013 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
ME030-C3 Vs. 31 03-11-2015 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
ME030-C3 Vs. 32 12-02-2016 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
ME030-C3 Vs. 35 08-06-2017 11p15 region, H19, IGF2, CDKN1C, KCNQ1 Beckwith-Wiedemann Syndrome (BWS), Russell-Silver Syndrome (RSS)
Vs. 08
09-03-2010
GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
Vs. 11
28-03-2012
GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
Vs. 12
20-12-2012
GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
ME031-B1 Vs.15 23-10-2013 GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
ME031-B1 Vs.16 01-06-2015 GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
ME031-B2 Vs.18 05-12-2016 GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
ME031-B2 Vs.19 07-06-2017 GNAS 20q13.32 Albright hereditary osteodystrophy (AHO), Pseudohypoparathyroidism (PHP)
Vs. 03 12-07-2013 UPD7/UPD14 Uniparental disomy
ME032-A1 Vs. 04 23-08-2013 UPD7/UPD14 Uniparental disomy
ME032-A1 Vs. 08 09-02-2017 UPD7/UPD14 Uniparental disomy
ME032-A1 Vs. 09 07-06-2017 UPD7/UPD14 Uniparental disomy
ME033-A1 Vs. 01 20-03-2014 6q24 Transient neonatal diabetes mellitus
ME033-A1 Vs. 03 11-01-2017 6q24 Transient neonatal diabetes mellitus
ME033-A1 Vs. 04 07-06-2017 6q24 Transient neonatal diabetes mellitus
ME034-A1 Vs. 01 17-10-2014 various Multi-locus Imprinting / Triploidy
ME034-A1 Vs. 06 07-06-2017 various Multi-locus Imprinting / Triploidy
ME042-C1 Vs. 09 17-02-2015 CIMP Methylation status in the CpG Island Methylator Phenotype
Vs. 04 20-12-2012 MLH1, MSH2, CDKN2A Lynch syndtrome
Vs. 05
12-10-2006
various Inflammation mRNA
Vs. 04
15-06-2006
various Apoptosis mRNA
Vs. 02
14-05-2008
various Apoptosis mRNA
Vs. 04
01-12-2010
various Apoptosis mRNA